The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Javier P. Gisbert

Department of Gastroenterology

Hospital Universitario de La Princesa

Instituto de Investigación Sanitaria Princesa

Madrid

Spain

[email]@meditex.es

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain. 1999 - 2012
  • Department of Gastroenterology and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IP), Madrid, Spain. 2008 - 2012

References

  1. Long-term follow-up of 1,000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding. Gisbert, J.P., Calvet, X., Cosme, A., Almela, P., Feu, F., Bory, F., Santolaria, S., Aznárez, R., Castro, M., Fernández, N., García-Grávalos, R., Benages, A., Cañete, N., Montoro, M., Borda, F., Pérez-Aisa, A., Piqué, J.M. Am. J. Gastroenterol. (2012) [Pubmed]
  2. Letter: third-line rescue therapy with levofloxacin after failure of two treatments to eradicate Helicobacter pylori infection. Gisbert, J.P. Aliment. Pharmacol. Ther. (2012) [Pubmed]
  3. Review article: rifabutin in the treatment of refractory Helicobacter pylori infection. Gisbert, J.P., Calvet, X. Aliment. Pharmacol. Ther. (2012) [Pubmed]
  4. Letter: the ethics of using inferior regimens in H. pylori randomised trials - invited comment. Gisbert, J.P. Aliment. Pharmacol. Ther. (2012) [Pubmed]
  5. Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease. Gisbert, J.P., Chaparro, M., Esteve, M. Aliment. Pharmacol. Ther. (2011) [Pubmed]
  6. The sequential therapy regimen for Helicobacter pylori eradication. Gisbert, J.P., Calvet, X., O'Connor, J.P., Mégraud, F., O'Morain, C.A. Expert. Opin. Pharmacother (2010) [Pubmed]
  7. Sequential therapy for Helicobacter pylori eradication: a critical review. Gisbert, J.P., Calvet, X., O'Connor, A., Mégraud, F., O'Morain, C.A. J. Clin. Gastroenterol. (2010) [Pubmed]
  8. Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding. Gisbert, J.P. Inflamm. Bowel Dis. (2010) [Pubmed]
  9. Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on ulcerative colitis: a real-life survey in Spain. Gisbert, J.P., Gomollón, F., Hinojosa, J., López San Román, A. J. Crohns. Colitis (2010) [Pubmed]
  10. Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin. Gisbert, J.P., Pérez-Aisa, A., Castro-Fernández, M., Barrio, J., Rodrigo, L., Cosme, A., Gisbert, J.L., Marcos, S., Moreno-Otero, R. Dig. Liver. Dis (2010) [Pubmed]
  11. Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review. Gisbert, J.P., Panés, J. Am. J. Gastroenterol. (2009) [Pubmed]
  12. Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study. Gisbert, J.P., Cooper, A., Karagiannis, D., Hatlebakk, J., Agréus, L., Jablonowski, H., Nuevo, J. Health. Qual. Life. Outcomes (2009) [Pubmed]
  13. Consultation rates and characteristics of gastro-oesophageal reflux disease in primary care: a European observational study. Gisbert, J.P., Cooper, A., Karagiannis, D., Hatlebakk, J., Agréus, L., Jablonowski, H., Tafalla, M. Eur. J. Gen. Pract (2009) [Pubmed]
  14. Second-line rescue therapy of helicobacter pylori infection. Gisbert, J.P. Therap. Adv. Gastroenterol (2009) [Pubmed]
  15. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Gisbert, J.P., Bermejo, F., Pérez-Calle, J.L., Taxonera, C., Vera, I., McNicholl, A.G., Algaba, A., López, P., López-Palacios, N., Calvo, M., González-Lama, Y., Carneros, J.A., Velasco, M., Maté, J. Inflamm. Bowel Dis. (2009) [Pubmed]
  16. Management of gastro-oesophageal reflux disease in primary care: a European observational study. Gisbert, J.P., Cooper, A., Karagiannis, D., Hatlebakk, J., Agréus, L., Jablonowski, H., Tafalla, M. Curr. Med. Res. Opin (2009) [Pubmed]
  17. Review article: Helicobacter pylori-negative duodenal ulcer disease. Gisbert, J.P., Calvet, X. Aliment. Pharmacol. Ther. (2009) [Pubmed]
  18. Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis. Gisbert, J.P., Linares, P.M., McNicholl, A.G., Maté, J., Gomollón, F. Aliment. Pharmacol. Ther. (2009) [Pubmed]
  19. Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement. Gisbert, J.P., Bermejo, F., Pajares, R., Pérez-Calle, J.L., Rodríguez, M., Algaba, A., Mancenido, N., de la Morena, F., Carneros, J.A., McNicholl, A.G., González-Lama, Y., Maté, J. Inflamm. Bowel Dis. (2009) [Pubmed]
  20. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Gisbert, J.P., McNicholl, A.G. Dig. Liver. Dis (2009) [Pubmed]
  21. Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease. Gisbert, J.P., McNicholl, A.G., Gomollon, F. Inflamm. Bowel Dis. (2009) [Pubmed]
  22. Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting. Gisbert, J.P., Cooper, A., Karagiannis, D., Hatlebakk, J., Agréus, L., Jablonowski, H., Zapardiel, J. Health. Qual. Life. Outcomes (2009) [Pubmed]
  23. Comparative effectiveness of azathioprine in Crohn's disease and ulcerative colitis: prospective, long-term, follow-up study of 394 patients. Gisbert, J.P., Niño, P., Cara, C., Rodrigo, L. Aliment. Pharmacol. Ther. (2008) [Pubmed]
  24. Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients. Gisbert, J.P., Gisbert, J.L., Marcos, S., Jimenez-Alonso, I., Moreno-Otero, R., Pajares, J.M. Aliment. Pharmacol. Ther. (2008) [Pubmed]
  25. "Rescue" regimens after Helicobacter pylori treatment failure. Gisbert, J.P. World J. Gastroenterol. (2008) [Pubmed]
  26. Effect of 5-aminosalicylates on renal function in patients with inflammatory bowel disease: 4-year follow-up study. Gisbert, J.P., Luna, M., González-Lama, Y., Pousa, I.D., Velasco, M., Moreno-Otero, R., Maté, J. Gastroenterol. Hepatol (2008) [Pubmed]
  27. Thiopurine methyltransferase activity in Spain: a study of 14,545 patients. Gisbert, J.P., Gomollón, F., Cara, C., Luna, M., González-Lama, Y., Pajares, J.M., Maté, J., Guijarro, L.G. Dig. Dis. Sci. (2007) [Pubmed]
  28. 5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review. Gisbert, J.P., González-Lama, Y., Maté, J. Inflamm. Bowel Dis. (2007) [Pubmed]
  29. First-line triple therapy with levofloxacin for Helicobacter pylori eradication. Gisbert, J.P., Fernández-Bermejo, M., Molina-Infante, J., Pérez-Gallardo, B., Prieto-Bermejo, A.B., Mateos-Rodríguez, J.M., Robledo-Andrés, P., González-García, G. Aliment. Pharmacol. Ther. (2007) [Pubmed]
  30. Liver injury in inflammatory bowel disease: long-term follow-up study of 786 patients. Gisbert, J.P., Luna, M., González-Lama, Y., Pousa, I.D., Velasco, M., Moreno-Otero, R., Maté, J. Inflamm. Bowel Dis. (2007) [Pubmed]
  31. Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding. Gisbert, J.P., Calvet, X., Feu, F., Bory, F., Cosme, A., Almela, P., Santolaria, S., Aznárez, R., Castro, M., Fernández, N., García-Grávalos, R., Cañete, N., Benages, A., Montoro, M., Borda, F., Pérez-Aisa, A., Piqué, J.M. Helicobacter (2007) [Pubmed]
  32. 13C-urea breath test during hospitalization for the diagnosis of Helicobacter pylori infection in peptic ulcer bleeding. Gisbert, J.P., Esteban, C., Jimenez, I., Moreno-Otero, R. Helicobacter (2007) [Pubmed]
  33. Systematic review: Infliximab therapy in ulcerative colitis. Gisbert, J.P., González-Lama, Y., Maté, J. Aliment. Pharmacol. Ther. (2007) [Pubmed]
  34. Levofloxacin- vs. ranitidine bismuth citrate-containing therapy after H. pylori treatment failure. Gisbert, J.P., Gisbert, J.L., Marcos, S., Moreno-Otero, R., Pajares, J.M. Helicobacter (2007) [Pubmed]
  35. Risk assessment and outpatient management in bleeding peptic ulcer. Gisbert, J.P., Legido, J., Castel, I., Trapero, M., Cantero, J., Maté, J., Pajares, J.M. J. Clin. Gastroenterol. (2006) [Pubmed]
  36. Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Gisbert, J.P., Morena, F. Aliment. Pharmacol. Ther. (2006) [Pubmed]
  37. Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies? Gisbert, J.P., Olivares, D., Jimenez, I., Pajares, J.M. Dig. Liver. Dis (2006) [Pubmed]
  38. Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures. Gisbert, J.P., Gisbert, J.L., Marcos, S., Moreno-Otero, R., Pajares, J.M. Aliment. Pharmacol. Ther. (2006) [Pubmed]
  39. Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients. Gisbert, J.P., Luna, M., Gómez, B., Herrerías, J.M., Monés, J., Castro-Fernández, M., Sánchez-Pobre, P., Cosme, A., Olivares, D., Pajares, J.M. Aliment. Pharmacol. Ther. (2006) [Pubmed]
  40. Long-term follow-up of 13C-urea breath test results after Helicobacter pylori eradication: frequency and significance of borderline delta13CO2 values. Gisbert, J.P., Olivares, D., Jimenez, I., Pajares, J.M. Aliment. Pharmacol. Ther. (2006) [Pubmed]
  41. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study. Gisbert, J.P., Luna, M., Maté, J., González-Guijarro, L., Cara, C., Pajares, J.M. Hepatogastroenterology (2006) [Pubmed]
  42. Clinical trial evaluating amoxicillin and clarithromycin hydrogels (Chitosan-polyacrylic acid polyionic complex) for H. pylori eradication. Gisbert, J.P., Torrado, G., Torrado, S., Olivares, D., Pajares, J.M. J. Clin. Gastroenterol. (2006) [Pubmed]
  43. Gastric MALT lymphoma: clinical characteristics and prevalence of H. pylori infection in a series of 37 cases. Gisbert, J.P., Aguado, B., Luna, M., Nistal, S., Asenjo, L.M., Reina, T., Acevedo, A., Arranz, R. Rev. Esp. Enferm. Dig (2006) [Pubmed]
  44. Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection. Gisbert, J.P., García-Buey, L., Pajares, J.M., Moreno-Otero, R. Aliment. Pharmacol. Ther. (2005) [Pubmed]
  45. Systematic review and meta-analysis: is 1-week proton pump inhibitor-based triple therapy sufficient to heal peptic ulcer?. Gisbert, J.P., Pajares, J.M. Aliment. Pharmacol. Ther. (2005) [Pubmed]
  46. 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure. Gisbert, J.P., Fuentes, J., Carpio, D., Tito, L., Guardiola, J., Tomas, A., Olivares, D., Calvet, X. Aliment. Pharmacol. Ther. (2005) [Pubmed]
  47. Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication. Gisbert, J.P., Gonzalez, L., Calvet, X. Helicobacter (2005) [Pubmed]
  48. Helicobacter pylori "rescue" therapy after failure of two eradication treatments. Gisbert, J.P., Pajares, J.M. Helicobacter (2005) [Pubmed]
  49. How effective are rescue H. pylori eradication therapies in patients with dyspepsia?. Gisbert, J.P. Nature Clinical Practice. Gastroenterology & Hepatology (2005) [Pubmed]
  50. Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin. Gisbert, J.P., Gisbert, J.L., Marcos, S., Olivares, D., Pajares, J.M. Aliment. Pharmacol. Ther. (2005) [Pubmed]
  51. 13C-urea breath test in the management of Helicobacterpylori infection. Gisbert, J.P., Pajares, J.M. Dig. Liver. Dis (2005) [Pubmed]
  52. Potent gastric acid inhibition in Helicobacter pylori eradication. Gisbert, J.P. Drugs (2005) [Pubmed]
  53. Evaluation of 3 different tests for the detection of stool antigens to confirm Helicobacter pylori eradication after treatment. A pilot study. Gisbert, J.P., Trapero, M., Pajares, J.M. Gastroenterol. Hepatol (2005) [Pubmed]
  54. Empirical Helicobacter pylori "rescue" therapy after failure of two eradication treatments. Gisbert, J.P., Gisbert, J.L., Marcos, S., Pajares, J.M. Dig. Liver. Dis (2004) [Pubmed]
  55. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs. Gisbert, J.P., Legido, J., García-Sanz, I., Pajares, J.M. Dig. Liver. Dis (2004) [Pubmed]
  56. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study. Gisbert, J.P., Cruzado, A.I., Garcia-Gravalos, R., Pajares, J.M. Hepatogastroenterology (2004) [Pubmed]
  57. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Gisbert, J.P., Khorrami, S., Carballo, F., Calvet, X., Gene, E., Dominguez-Muñoz, E. Aliment. Pharmacol. Ther. (2004) [Pubmed]
  58. The prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Gisbert, J.P., García-Buey, L., Arranz, R., Blas, C., Pinilla, I., Khorrami, S., Acevedo, A., Borque, M.J., Pajares, J.M., Fernández-Rañada, J.M., Moreno-Otero, R. Eur. J. Gastroenterol. Hepatol (2004) [Pubmed]
  59. Evaluation of three different tests for the detection of stool antigens to diagnose Helicobacter pylori infection in patients with upper gastrointestinal bleeding. Gisbert, J.P., Trapero, M., Calvet, X., Mendoza, J., Quesada, M., Güell, M., Pajares, J.M. Aliment. Pharmacol. Ther. (2004) [Pubmed]
  60. Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis. Gisbert, J.P., Khorrami, S., Calvet, X., Pajares, J.M. Eur. J. Gastroenterol. Hepatol (2004) [Pubmed]
  61. Esomeprazole-based therapy in Helicobacter pylori eradication: a meta-analysis. Gisbert, J.P., Pajares, J.M. Dig. Liver. Dis (2004) [Pubmed]
  62. Hepatocellular carcinoma risk in patients with porphyria cutanea tarda. Gisbert, J.P., García-Buey, L., Alonso, A., Rubio, S., Hernández, A., Pajares, J.M., García-Díez, A., Moreno-Otero, R. Eur. J. Gastroenterol. Hepatol (2004) [Pubmed]
  63. Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review. Gisbert, J.P., Pajares, J.M. Helicobacter (2004) [Pubmed]
  64. Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical review. Gisbert, J.P., Pajares, J.M. Aliment. Pharmacol. Ther. (2004) [Pubmed]
  65. Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?. Gisbert, J.P., Jones, E.A., Pajares, J.M., Moreno-Otero, R. Aliment. Pharmacol. Ther. (2003) [Pubmed]
  66. Treatment of Helicobacter pylori Eradication Failures. Gisbert, J.P., Pajares, J.M. Curr. Treat. Options. Gastroenterol (2003) [Pubmed]
  67. Systematic review: Rabeprazole-based therapies in Helicobacter pylori eradication. Gisbert, J.P., Khorrami, S., Calvet, X., Pajares, J.M. Aliment. Pharmacol. Ther. (2003) [Pubmed]
  68. Validation of the 13c-urea breath test for the initial diagnosis of helicobacter pylori infection and to confirm eradication after treatment. Gisbert, J.P., Ducons, J., Gomollón, F., Domínguez-Muñoz, J.E., Borda, F., Miño, G., Jiménez, I., Vázquez, M.A., Santolaria, S., Gallego, S., Iglesias, J., Pastor, G., Hervás, A., Pajares, J.M. Rev. Esp. Enferm. Dig (2003) [Pubmed]
  69. Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis. Gisbert, J.P., García-Buey, L., Pajares, J.M., Moreno-Otero, R. J. Hepatol. (2003) [Pubmed]
  70. Meta-analysis: proton pump inhibitors vs. H2-receptor antagonists--their efficacy with antibiotics in Helicobacter pylori eradication. Gisbert, J.P., Khorrami, S., Calvet, X., Gabriel, R., Carballo, F., Pajares, J.M. Aliment. Pharmacol. Ther. (2003) [Pubmed]
  71. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Gisbert, J.P., Khorrami, S., Carballo, F., Calvet, X., Gené, E., Dominguez-Muñoz, J.E. Cochrane. Database. Syst. Rev (2003) [Pubmed]
  72. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gisbert, J.P., García-Buey, L., Pajares, J.M., Moreno-Otero, R. Gastroenterology (2003) [Pubmed]
  73. Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail. Gisbert, J.P., Pajares, J.M. Aliment. Pharmacol. Ther. (2002) [Pubmed]
  74. Review article: Helicobacter pylori infection and gastric outlet obstruction - prevalence of the infection and role of antimicrobial treatment. Gisbert, J.P., Pajares, J.M. Aliment. Pharmacol. Ther. (2002) [Pubmed]
  75. Role of partner's infection in reinfection after Helicobacter pylori eradication. Gisbert, J.P., Arata, I.G., Boixeda, D., Barba, M., Cantón, R., Plaza, A.G., Pajares, J.M. Eur. J. Gastroenterol. Hepatol (2002) [Pubmed]
  76. Helicobacter pylori and gastroesophageal reflux disease: lack of influence of infection on twenty-four-hour esophageal pH monitoring and endoscopic findings. Gisbert, J.P., de Pedro, A., Losa, C., Barreiro, A., Pajares, J.M. J. Clin. Gastroenterol. (2001) [Pubmed]
  77. Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer. Gisbert, J.P., González, L., Calvet, X., Roqué, M., Gabriel, R., Pajares, J.M. Aliment. Pharmacol. Ther. (2001) [Pubmed]
  78. Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs. Gisbert, J.P., Gonzalez, L., de Pedro, A., Valbuena, M., Prieto, B., Llorca, I., Briz, R., Khorrami, S., Garcia-Gravalos, R., Pajares, J.M. Scand. J. Gastroenterol. (2001) [Pubmed]
  79. Helicobacter pylori therapy: first-line options and rescue regimen. Gisbert, J.P., Pajares, J.M. Dig. Dis (2001) [Pubmed]
  80. Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia?. Gisbert, J.P., Hermida, C., Pajares, J.M. Hepatogastroenterology (2001) [Pubmed]
  81. Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia. Gisbert, J.P., Marcos, S., Gisbert, J.L., Pajares, J.M. Eur. J. Gastroenterol. Hepatol (2001) [Pubmed]
  82. Helicobacter pylori "test-and-scope" strategy for dyspeptic patients. Is it useful and safe?. Gisbert, J.P., Cruzado, A.I., Benito, L.M., Carpio, D., Perez-Poveda, J.J., Gonzalez, L., de Pedro, A., Valbuena, M., Prieto, B., Cabrera, M.M., Cantero, J., Pajares, J.M. Dig. Liver. Dis (2001) [Pubmed]
  83. One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication. Gisbert, J.P., Carpio, D., Marcos, S., Gisbert, J.L., García Grávalos, R., Pajares, J.M. Eur. J. Gastroenterol. Hepatol (2000) [Pubmed]
  84. Helicobacter pylori "test-and-scope" strategy for dyspeptic patients. Gisbert, J.P., Pajares, J.M. Helicobacter (2000) [Pubmed]
  85. Value of quantitative serology for confirmation of Helicobacter pylori eradication: an 18-month follow-up study. Gisbert, J.P., Blanco, M., Benito, L.M., Pajares, J.M. Clin. Infect. Dis. (2000) [Pubmed]
  86. Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy. Gisbert, J.P., González, L., Calvet, X., Roqué, M., Gabriel, R., Pajares, J.M. Aliment. Pharmacol. Ther. (2000) [Pubmed]
  87. 13C-urea breath test for the diagnosis of Helicobacter pylori infection before treatment: is citric acid necessary?. Gisbert, J.P., Vazquez, M.A., Jimenez, I., Cruzado, A.I., Carpio, D., Del Castillo, E., Martin, M.J., Morales, A., Pajares, R., Rodriguez, A., Pajares, J.M. Dig. Liver. Dis (2000) [Pubmed]
  88. Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. Gisbert, J.P., González, L., Calvet, X., García, N., López, T., Roqué, M., Gabriel, R., Pajares, J.M. Aliment. Pharmacol. Ther. (2000) [Pubmed]
  89. Esophageal achalasia. Review of its clinical, diagnostic and therapeutic aspects. Gisbert, J.P., Losa, C., Barreiro, A., Pajares, J.M. Rev. Clin. Esp (2000) [Pubmed]
  90. 13C-urea breath test for the diagnosis of Helicobacter pylori infection: are basal samples necessary?. Gisbert, J.P., Benito, L.M., Lara, S., Vázquez, A., Jiménez, I., Pajares, J.M. Eur. J. Gastroenterol. Hepatol (2000) [Pubmed]
  91. Helicobacter pylori infection, gastric metaplasia in the duodenum and the relationship with ulcer recurrence. Gisbert, J.P., Blanco, M., Cruzado, A.I., Pajares, J.M. Eur. J. Gastroenterol. Hepatol (2000) [Pubmed]
  92. Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori: a 1-year follow-up study. Gisbert, J.P., Boixeda, D., Al-Mostafa, A., Vila, T., de Rafael, L., Alvarez Baleriola, I., de Argila, C.M., Abraira, V. Eur. J. Gastroenterol. Hepatol (1999) [Pubmed]
  93. Helicobacter pylori and gastroesophageal reflux disease: friends or foes?. Gisbert, J.P., Pajares, J.M., Losa, C. Hepatogastroenterology (1999) [Pubmed]
  94. Re-treatment after Helicobacter pylori eradication failure. Gisbert, J.P., Boixeda, D., Bermejo, F., Nieves Rincón, M., Jesús Higes, M., Angeles Arpa, M., García Arata, I., Martín de Argila, C., García Plaza, A. Eur. J. Gastroenterol. Hepatol (1999) [Pubmed]
  95. Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole. Gisbert, J.P., Gisbert, J.L., Marcos, S., Grávalos, R.G., Carpio, D., Pajares, J.M. Aliment. Pharmacol. Ther. (1999) [Pubmed]
 
WikiGenes - Universities